Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zonisamide effective against binge eating, although not well tolerated

Feb. 7, 2007

Recent patents report novel therapeutic agents for metabolic diseases

Feb. 6, 2007

DiaKine Therapeutics and AdPharma to develop pipeline for reversing diabetes

Feb. 6, 2007

Japanese phase I testing of Hematide triggers milestone payment

Feb. 5, 2007

Enrollment complete in phase IIb diabetes study of CS-917

Feb. 5, 2007

Novel metabolic drugs reported in recent patent literature

Feb. 5, 2007

Enrollment target reached in phase II study of MD-05 in dental implantology

Feb. 2, 2007

AstraZeneca and Palatin collaborate in obesity

Feb. 2, 2007

FDA awards orphan drug status to Gestiva for prevention of preterm birth

Feb. 2, 2007

End-of-phase II meeting for Diamyd

Feb. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...